#AMT130
Join the Fight to Bring Hope to HD Families: Urge the FDA to Uphold Accelerated Approval!

www.change.org/p/bring-hope...

#hdreachgameoverhd #huntingtonsdisease #fyp #raredisease #amt130 #fda #advocacy #petition
November 25, 2025 at 10:09 PM
Gene therapy developer uniQure announced plans to submit a Biologics License Application for its Huntington’s disease treatment, AMT-130, following positive feedback from the FDA.

https://azat.tv/en/uniqure-amt130-fda-submission/
June 17, 2026 at 7:48 PM
And Uniqure’s AMT130 gene therapy safe & well tolerated at 24mo (low dose), 12mo (high). Claims of efficacy signal less clear but NFL below baseline is definitely encouraging & should be helped by short steroid treatment of future cases

https://www.uniqure.com/investors-media/press-releases
June 21, 2023 at 12:30 PM
CIENCIA. El AMT-130 se posiciona como el "santo grial" contra la enfermedad de Huntington. Según expertos, esta terapia génica pionera ofrece los datos más sólidos vistos hasta hoy. Lee más aquí: www.cronicadelhenares.com/2025/12/salu... #AMT130 #Neurología #Huntington #Salud #TerapiaGénica
SALUD. AMT-130: ¿El "Santo Grial" contra la Enfermedad de Huntington?
salud, fármacos, AMT-130, Enfermedad de Huntington, neurociencia, terapias génicas
www.cronicadelhenares.com
December 8, 2025 at 7:07 PM
AMT-130, an investigational #GeneTherapy for #HuntingtonDisease (HD), will likely require a large controlled trial before it can be considered for approval, uniQure announced.

Read more: https://bit.ly/4sfOrFo

#RareDisease #AMT130 #ClinicalTrial
HD Gene Therapy AMT-130 Faces Requirement for Large Controlled Trial Before FDA Approval
AMT-130, an investigational gene therapy for HD, will likely require a large controlled trial before the FDA will consider it for approval.
www.rarediseaseadvisor.com
March 4, 2026 at 5:15 PM